These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10231079)

  • 41. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda.
    Vlahov D
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S3-6. PubMed ID: 7865324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.
    Wolfe D; Carrieri MP; Shepard D
    Lancet; 2010 Jul; 376(9738):355-66. PubMed ID: 20650513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency.
    Dandona L; Sisodia P; Kumar SG; Ramesh YK; Kumar AA; Rao MC; Marseille E; Someshwar M; Marshall N; Kahn JG
    BMC Public Health; 2005 Sep; 5():98. PubMed ID: 16181491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam.
    Tran BX; Ohinmaa A; Duong AT; Do NT; Nguyen LT; Mills S; Houston S; Jacobs P
    AIDS Care; 2012; 24(3):283-90. PubMed ID: 21936718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors related to delayed diagnosis of HIV infection in southeastern France. EVALVIH group.
    Rotily M; Bentz L; Pradier C; Obadia Y; Cavailler P
    Int J STD AIDS; 2000 Aug; 11(8):531-5. PubMed ID: 10990338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Association of Nurses in AIDS Care. Position paper on harm reduction and HIV care for drug users: integrating harm-reduction methods and HIV care.
    Fisk SN
    J Assoc Nurses AIDS Care; 1998; 9(3):19-24. PubMed ID: 9589418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevalence of HIV infection among drug users in Zuid-Limburg].
    Wiessing LG; Houweling H; Meulders WA; Cerdá E; Jansen M; Sprenger MJ
    Ned Tijdschr Geneeskd; 1995 Sep; 139(38):1936-40. PubMed ID: 7477534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.
    Strathdee SA; Shoptaw S; Dyer TP; Quan VM; Aramrattana A;
    Curr Opin HIV AIDS; 2012 Jul; 7(4):320-5. PubMed ID: 22498479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of HIV counseling and testing in US prisons.
    Varghese B; Peterman TA
    J Urban Health; 2001 Jun; 78(2):304-12. PubMed ID: 11419583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.
    Hilton BA; Thompson R; Moore-Dempsey L; Janzen RG
    J Adv Nurs; 2001 Feb; 33(3):357-70. PubMed ID: 11251723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine.
    Vickerman P; Kumaranayake L; Balakireva O; Guinness L; Artyukh O; Semikop T; Yaremenko O; Watts C
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S89-102. PubMed ID: 16735956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Admissions of injection drug users to drug abuse treatment following HIV counseling and testing.
    McCusker J; Willis G; McDonald M; Lewis BF; Sereti SM; Feldman ZT
    Public Health Rep; 1994; 109(2):212-8. PubMed ID: 8153272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Costs of voluntary rapid HIV testing and counseling in jails in 4 states--advancing HIV Prevention Demonstration Project, 2003-2006.
    Shrestha RK; Sansom SL; Richardson-Moore A; French PT; Scalco B; Lalota M; Llanas M; Stodola J; Macgowan R; Margolis A
    Sex Transm Dis; 2009 Feb; 36(2 Suppl):S5-8. PubMed ID: 19222142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY.
    Gourevitch MN; Hartel D; Schoenbaum EE; Selwyn PA; Davenny K; Friedland GH; Klein RS
    Am J Public Health; 1996 Aug; 86(8):1112-5. PubMed ID: 8712270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug abuse, methadone treatment, and health services use among injection drug users with AIDS.
    Sambamoorthi U; Warner LA; Crystal S; Walkup J
    Drug Alcohol Depend; 2000 Jul; 60(1):77-89. PubMed ID: 10821992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of sex partners' HIV status on HIV seroconversion in a prospective cohort of injection drug users.
    Kerr T; Stoltz JA; Strathdee S; Li K; Hogg RS; Montaner JS; Wood E
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):119-23. PubMed ID: 16340484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV voluntary counseling and testing and HIV incidence in male injecting drug users in northern Thailand: evidence of an urgent need for HIV prevention.
    Kawichai S; Celentano DD; Vongchak T; Beyrer C; Suriyanon V; Razak MH; Srirak N; Rungruengthanakit K; Jittiwutikarn J
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):186-93. PubMed ID: 16394851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV prevention intervention for substance users: a review of the literature.
    Elkbuli A; Polcz V; Dowd B; McKenney M; Prado G
    Subst Abuse Treat Prev Policy; 2019 Jan; 14(1):1. PubMed ID: 30606266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV transmission and the cost-effectiveness of methadone maintenance.
    Zaric GS; Barnett PG; Brandeau ML
    Am J Public Health; 2000 Jul; 90(7):1100-11. PubMed ID: 10897189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.